Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance()

JS-K is a nitric oxide (NO)-releasing prodrug of the O(2)-arylated diazeniumdiolate family that has demonstrated pronounced cytotoxicity and antitumor properties in a variety of cancer models both in vitro and in vivo. The current study of the metabolic actions of JS-K was undertaken to investigate...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Maciag, Anna E., Holland, Ryan J., Robert Cheng, Y.-S., Rodriguez, Luis G., Saavedra, Joseph E., Anderson, Lucy M., Keefer, Larry K.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2013
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3757670/
https://ncbi.nlm.nih.gov/pubmed/24024144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.redox.2012.12.002
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items